What upstream signals activate the prosaposin-GPR37-IL-6 axis specifically in oligodendrocytes during PD?

OPEN

While the study identifies this novel signaling pathway in oligodendrocytes, the initial triggers that activate prosaposin release or GPR37 expression remain unexplained. This mechanistic gap limits understanding of disease initiation. Gap type: unexplained_observation Source paper: Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson's disease via the prosaposin-GPR37-IL-6 axis. (2025, Cell Rep, PMID:39913287)

Priority: 0.82 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What upstream signals activate the prosaposin-GPR37-IL-6 axis specifically in oligodendrocytes during PD? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What upstream signals activate the prosaposin-GPR37-IL-6 axis specifically in oligodendrocytes during PD? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (7)

269BP_ALLELEPD271BP_ALLELEPD265BP_ALLELEPDKEAP1PDBCL2PD
▸ Show 2 more

associated with (13)

PARKINPDTNFPDPINK1PDNLRP3PDNEUROINFLAMMATIONPD
▸ Show 8 more

causes (14)

PDDOPAMINERGIC_NEURONSPDNEURODEGENERATIONLRRK2PDalpha_synucleinPDVPS35PD
▸ Show 9 more

contributes to (1)

PDsynucleinopathies

cross disease mechanism in (6)

SNCAPDMAPTPDTREM2PDNLRP3PDPINK1PD
▸ Show 1 more

describes (1)

therapeutics-adenosine-a2a-receptor-antagonists-pdPD

increases risk (1)

GBA1 mutationsPD

inhibits (1)

267BP_ALLELEPD

interacts with (2)

NRF2PDPDTAU

protects against (2)

NRF2PDKEAP1PD

regulates (1)

TP53PD

treats (1)

EPSPD
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps